BIZARRE: Is wall street bullish or bearish on pfizer stock | Mind Blowing Facts

New York-based Pfizer Inc. (PFE) is a leading global biopharmaceutical company with a strong market cap of $173.1 billion, focused on the discovery, development, and marketing of innovative drugs and vaccines. The company operates in multiple therapeutic areas and maintains strategic collaborations with major pharmaceutical companies.

Shares of the pharmaceutical giant have significantly underperformed the broader market over the past 52 weeks. PFE has decreased 14.2% over this time frame, while the broader S&P 500 Index ($SPX) has rallied 20.5%. However, in 2024, PFE climbed into positive territory, with shares up 5%, but still lags behind the SPX's 15.8% gains on a YTD basis.